retatrutide phase 2 results obesity nejm 2023 🤔 Adults with type diabetes (T2D) and lose less weight on EVERY GLP-1 drug compared to those without diabetes, consistently ~5% less. Now that we have retatrutide's TRIUMPH-2 data today Retatrutide vs Semaglutide: Triple vs

The range in clinical trials runs from about 25% to 40%, depending on the drug, dose, duration, and whether participants were exercising and eating adequate protein

Data from cardiovascular outcomes trials suggest that GLP-1 agonists provide cardioprotective effects independent of weight loss, including reduced myocardial infarction rates and improved heart failure outcomes

Weight Loss and Psychological Transformation Beyond the direct neurochemical effects, the weight loss itself profoundly impacts mental health

GLP-1 medications arent a quick fix theyre meant to be taken long-term even if you reach your A1c and weight loss goals

do not freeze the solution or use if it has been exposed to extreme temperatures